Arrowhead PharmaceuticalsARWR 
$19.45-0.26%24h
-0.26%24h
Global rank4621
Market cap$2.08B
Change 7d-10.29%
YTD Performance-36.23%
SP500 benchmarkUnderperform
P/E-10.13
P/S8.62
Revenue$240.74M
Earnings-$209.28M
Dividend yield-
Main Sector
Healthcare
Arrowhead Pharmaceuticals (ARWR) Net Assets
ARWR Net Assets in 2023: $287.16M
As of 21 Dec 2024, Arrowhead Pharmaceuticals net assets is $287.16M, an decrease of -31.36% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Arrowhead Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Arrowhead Pharmaceuticals Net Assets History from 2018 to 2024
-
Value:-
ARWR Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $287.16M | -31.36% |
| 2022 | $418.34M | 2.33% |
| 2021 | $408.82M | -11.47% |
| 2020 | $461.78M | 89.23% |
| 2019 | $244.04M | -150.10% |
| 2018 | $-487.11M | - |
View the Top Net Assets Companies
